Cytogen Inc (217330) — Financial Flexibility Index
Cytogen Inc (217330) has a Financial Flexibility Index of -0.08x as of December 2025. Free cash flow of ₩-2.08 Billion (operating CF ₩-2.13 Billion minus capex ₩49.52 Million) represents 0% of total liabilities (₩26.25 Billion). Also explore 217330 net assets growth trend to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Cytogen Inc Financial Flexibility Index (2014–2025)
Historical Financial Flexibility Index trend for Cytogen Inc across 12 annual periods. Check Cytogen Inc (217330) strategic asset index to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for Cytogen Inc (2014–2025)
Year-by-year free cash flow to debt coverage for Cytogen Inc. For the full company profile including market capitalisation, see market cap of Cytogen Inc.
| Year | Flexibility Index | Free Cash Flow (KRW) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.19x | ₩-4.92 Billion | ₩-6.95 Billion | ₩26.25 Billion | ▲ +46.8% |
| 2024 | -0.35x | ₩-8.41 Billion | ₩-9.53 Billion | ₩23.89 Billion | ▼ -49.3% |
| 2023 | -0.24x | ₩-4.97 Billion | ₩-7.59 Billion | ₩21.09 Billion | ▼ -48.8% |
| 2022 | -0.16x | ₩-5.63 Billion | ₩-6.38 Billion | ₩35.56 Billion | ▼ -59.3% |
| 2021 | -0.10x | ₩-3.23 Billion | ₩-5.23 Billion | ₩32.52 Billion | ▲ +76.4% |
| 2020 | -0.42x | ₩-4.20 Billion | ₩-4.47 Billion | ₩9.97 Billion | ▲ +73.1% |
| 2019 | -1.56x | ₩-2.81 Billion | ₩-3.37 Billion | ₩1.80 Billion | ▲ +23.7% |
| 2018 | -2.05x | ₩-1.46 Billion | ₩-2.77 Billion | ₩711.51 Million | ▼ -4.1% |
| 2017 | -1.97x | ₩-1.86 Billion | ₩-2.18 Billion | ₩947.50 Million | ▼ -347.6% |
| 2016 | -0.44x | ₩-2.02 Billion | ₩-2.36 Billion | ₩4.59 Billion | ▲ +58.1% |
| 2015 | -1.05x | ₩-1.67 Billion | ₩-2.03 Billion | ₩1.60 Billion | ▼ -250.0% |
| 2014 | -0.30x | ₩-470.57 Million | ₩-1.03 Billion | ₩1.57 Billion | — |